FOXJ3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.243000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.091600E-01
Normal-vs-Stage2
3.631400E-01
Normal-vs-Stage3
3.402200E-02
Normal-vs-Stage4
7.629200E-01
Stage1-vs-Stage2
8.160200E-01
Stage1-vs-Stage3
2.936200E-02
Stage1-vs-Stage4
5.979200E-01
Stage2-vs-Stage3
1.103370E-01
Stage2-vs-Stage4
5.074800E-01
Stage3-vs-Stage4
3.227800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.382800E-01
Normal-vs-AfricanAmerican
5.835200E-01
Normal-vs-Asian
1.797810E-01
Caucasian-vs-AfricanAmerican
6.157000E-01
Caucasian-vs-Asian
3.734400E-01
AfricanAmerican-vs-Asian
2.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.771600E-01
Normal-vs-Female
2.598000E-01
Male-vs-Female
9.322400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.684400E-01
Normal-vs-Age(41-60Yrs)
4.385800E-01
Normal-vs-Age(61-80Yrs)
2.928400E-01
Normal-vs-Age(81-100Yrs)
3.398400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.761600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.312600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.431000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.446310E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.082200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.817400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.837570E-01
Normal-vs-Daily Drinker
8.861600E-02
Normal-vs-Weekly Drinker
6.923800E-02
Normal-vs-Occasional Drinker
4.802600E-01
Normal-vs-Social Drinker
3.800000E-01
Non Drinker-vs-Daily Drinker
7.674200E-01
Non Drinker-vs-Weekly Drinker
5.099200E-01
Non Drinker-vs-Occasional Drinker
9.351600E-02
Non Drinker-vs-Social Drinker
2.638600E-01
Daily Drinker-vs-Weekly Drinker
6.497200E-01
Daily Drinker-vs-Occasional Drinker
3.428400E-02
Daily Drinker-vs-Social Drinker
1.344600E-01
Weekly Drinker-vs-Occasional Drinker
2.093900E-02
Weekly Drinker-vs-Social Drinker
8.293900E-02
Occasional Drinker-vs-Social Drinker
6.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.681400E-01
Normal-vs-Grade 2
4.896400E-02
Normal-vs-Grade 3
6.694500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.971800E-01
Grade 1-vs-Grade 3
7.901800E-01
Grade 1-vs-Grade 4
3.681400E-01
Grade 2-vs-Grade 3
9.669600E-01
Grade 2-vs-Grade 4
4.896400E-02
Grade 3-vs-Grade 4
6.694500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.357650E-01
Normal-vs-NonDiabetic
1.301010E-01
Diabetic-vs-NonDiabetic
5.956600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.208170E-01
Normal-vs-NoPancreatitis
1.520380E-01
Pancreatitis-vs-NoPancreatitis
9.615000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.245600E-01
Normal-vs-N1
3.803200E-01
N0-vs-N1
6.093400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.976800E-01
Normal-vs-TP53-NonMutant
6.669200E-01
TP53-Mutant-vs-TP53-NonMutant
5.913200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
